Table 2.
Baseline socio-demographic characteristics by the intervention and control groups.
| Variables | Intervention N = 403 | Control N = 388 | Total N = 791 |
|---|---|---|---|
| Parent level socio-demographics | |||
| Age (SD) | 37.6 ± 5.7 | 37.8 ± 5.4 | 37.7 ± 5.6 |
| Gender | |||
| Male | 231 (57.3%) | 224 (57.7%) | 455 (57.5%) |
| Female | 172 (42.7%) | 164 (42.3%) | 336 (42.5%) |
| Marital status | |||
| Married | 303 (75.4%) | 301 (77.6%) | 604 (76.5%) |
| Separated/divorced | 41 (10.2%) | 41 (10.6%) | 82 (10.4%) |
| Widowed | 58 (14.4%) | 46 (11.9%) | 104 (13.2%) |
| Education completed | |||
| Primary school | 169 (43.0%) | 186 (50.3%) | 355 (46.5%) |
| Middle school | 195 (49.6%) | 156 (42.2%) | 351 (46.0%) |
| High school and higher | 29 (7.4%) | 28 (7.6%) | 57 (7.5%) |
| Employment status | |||
| Unemployed | 97 (24.1%) | 58 (15.2%) | 155 (19.8%) |
| Part-time | 131 (32.6%) | 131 (34.3%) | 262 (33.4%) |
| Full-time | 174 (43.3%) | 193 (50.5%) | 367 (46.8%) |
| Household's monthly income (CNY) | |||
| 0–999 | 20 (57.1%) | 199 (51.3%) | 429 (54.2%) |
| 1,000–1,999 | 125 (31.0%) | 130 (33.5%) | 255 (32.2%) |
| ≥2,000 | 48 (11.9%) | 59 (15.2%) | 107 (13.5%) |
| Clinical-related | |||
| Route of infection | |||
| Spouse/main partner | 144 (35.7%) | 135 (34.8%) | 279 (35.3%) |
| Commercial sex | 121 (30.0%) | 143 (36.9%) | 264 (33.4%) |
| Injecting drug use | 58 (14.4%) | 49 (12.6%) | 107 (13.5%) |
| Others | 80 (19.9%) | 61 (15.7%) | 141 (17.8%) |
| CD4 group (copies/ml) | |||
| <200 | 77 (19.5%) | 69 (18.8%) | 146 (19.1%) |
| 200–349 | 121 (30.6%) | 117 (31.8%) | 238 (31.2%) |
| 350–500 | 99 (25.1%) | 98 (26.6%) | 197 (25.8%) |
| ≥500 | 98 (24.8%) | 84 (22.8%) | 182 (23.9%) |
| Child-level | |||
| Age group | |||
| 6–9 | 199 (49.3%) | 172 (46.0%) | 371 (47.7%) |
| 10–12 | 110 (27.2%) | 86 (23.0%) | 196 (25.2%) |
| 13–15 | 95 (23.5%) | 116 (31.0%) | 211 (27.1%) |
| Gender | |||
| Male | 209 (54.1%) | 185 (51.8%) | 394 (53.0%) |
| Female | 177 (45.9%) | 172 (48.2%) | 349 (47.0%) |